Executive Director’s Column
Geoff Thompson, MA,
CCC
Harm reduction (HR) approaches to addiction
treatment are famous mostly for ending up on the front pages of
newspapers: tax-payer funded sites for injection drug users to shoot
up, supplying heroin to heroin addicts, needle exchanges, and the
like. Disciples of abstinence denounce loudly such efforts, but
an increasing number of healthcare professionals are touting its
benefits. More than simply helping addicts use safely, HR is a collection
of strategies and techniques that have in common the idea that successful
treatment reduces the harm that drugs cause to the addict, his family,
and society.
Although HR has a history in many parts
of Europe, it is a relatively new movement in North America. Policy
and clinical experts have been struggling to understand how HR can
work within the American (and Canadian) context, known for its zero-tolerance
for drug use. Today, it remains vaguely defined and includes interventions
as diverse as training servers in a bar, providing drugs to palliative
care patients, implementing controlled drinking programs, and working
with clients who relapse in treatment. The Alberta Alcohol and Drug
Abuse Commission (AADAC) is typical of the ambivalent attitude.
Worried of offending abstinence service providers, AADAC (1999)
attempted to assuage them by suggesting that:
Harm reduction can be complementary
to the abstinence model of addictions treatment. Providing injection
drug users with clean needles and syringes, for example, is a
strategy for reducing immediate risk of serious health consequences
and limiting the spread of HIV. Yet needle exchange programs can
also link drug users to programs that treat drug dependency.
The statement describes both HR and abstinence
approaches only at the superficial level of drug use, the level
that is an affront to prohibition. Indeed, HR literature reports
that the approach arose mainly as a response to the growing incidence
of HIV/AIDS infection (see, for eg, AADAC, 1999; Marlatt, 1998).
Controlling infectious diseases, including Hepatitis, was the main
impetus for needle exchange programs. And AADAC (1999) goes out
of its way to comment that “harm reduction is not the same
as legalization or decriminalization.”
Yet the logical inconsistency is obvious: on
the one hand, for instance, providing safe injection sites and safe
smoking sites (for crack cocaine and crystal methamphetamine), while
on the other declaring that possession of controlled substances
is a criminal act. I find it amusing to read the various positions
of Vancouver policy makers and the federal drug policy makers over
the appropriateness of, for example, the North American Opiate Medication
Initiative (NAOMI), which provides heroin to heroin addicts. The
federal minister of health has publicly announced that heroin is
illegal in this country at the same time as Vancouver pushes to
continue the project. And now Vancouver City Council (June 14, 2007)
passed a motion that approved the objectives and principles of the
Chronic Addiction Substitution Treatment (CAST), which will provide
free mood-altering prescription drugs to cocaine and methamphetamine
addicts, at an estimated cost of $10 million. (The cost of HIV among
injection drug users in the notorious Downtown Eastside is $215,852,613
according to a 2004 report.)
HR as a response to the moral perspective
But the difference in approaches is far more
comprehensive, and many believe they are incompatible (see, for
eg, Peele, 2004). Two conflicting issues are the moral and epistemological
stances. Increasingly, the literature is highlighting current discomfort
with prevailing abstinence-based clinical practice that is rooted
in a rigid moral and biological reductionist thinking. Typical of
the new view is the comment of one service provider: “These
[clients] are people who are on a journey…. It’s not
right that we only accompany people on their journey if they do
it our way” (Editorial, 2001, p. 2). The traditional abstinence
program took control of clients, demanding that they behave according
to an imposed standard and punished those who did not measure up.
Marlatt (1998) thus described HR as a humane approach that avoids
the shaming finger of the moral perspective and the deterministic
medical perspective. Traditional treatment had demanded behavior
for addicts that was never applied to any other health condition.
What physician would punish a heart patient or a diabetic for not
following his medication regime? But in addictions treatment, the
carrot-and-stick approach was so common that many assumed it was
the only treatment.
The moral influence had demanded prohibition,
which had left many addicts marginalized. HR advocates said: ‘Look,
we know that people have been using excessively for millennia, and
all our efforts at prohibition don’t work. So let’s
deal with reality and do what we can to help’.
Unlike abstinence approaches to treatment, HR
is also concerned with families of addicts and with their communities.
A 1999 HR conference provided a series of principles for service
providers, one of which emphasized: “Service providers are
responsible to the wider community for delivering interventions
which will reduce the economic, social and physical consequences
of substance abuse and misuse” (Editorial, 2001, p. 2).
Advocates of HR thus bring the message that
it as a more ethical way to conduct therapy.
HR and post-modern epistemology
HR is consistently described as “practical”
(see, for eg, AADAC, 1999; Marlatt, 1998), and few have commented
on its philosophical basis, which is rooted in a post-modern epistemology.
It recognizes that programs that set particular standards of behavior
(for eg, abstinence as a prerequisite for recovery) or motivations
(for eg, determining who is and is not ‘ready’ for treatment)
say more about the assumed epistemological stance of program providers
than they do about the reality of addiction. The shift to a post-modern
epistemology has been a struggle. Until relatively recently, for
instance, traditional scientific psychologists have relied on quantitative
research studies and often dismissed qualitative studies as being
vague and not the proper purview of psychology. Today, however,
qualitative research is generally accepted, as psychology has recognized
the soundness of its foundations, which were proposed by the philosopher
Edmund Husserl and other thinkers. Jerome Bruner (1991) is often
cited in psychology as presenting a clear explanation of the new
thinking. He points out that much of what we believe to be the ‘truth’
is really an assumption that the traditional scientific method,
what Bruner calls “paradigmatic reasoning,” is the only
way to enlightenment. With post-modern epistemology, however, we
have accepted that “narrative reasoning” is equally
valid.
Narrative reasoning says that each of us views
the world through an individual lens. Given this, it is not realistic
to suggest that one’s view is the truth, because what the
individual sees is filtered through her unique experiences and physical
brain. Qualitative research thus does not concern itself with the
‘truth’ of phenomena, but rather with their meaning.
The more lenses through which we view something, the richer the
meaning we find. Under narrative thinking, it is thus highly questionable
for therapists to set arbitrary standards because this is the particular
lens of the therapists, not some absolute truth. Rather than rely
solely on ‘experts’, HR invites addicts to contribute
to the discussion on treatment, because the addicts’ views
are equally valid. In fact, commentators have often called HR a
grassroots movement (see, for eg, Marlatt, 1998).
Theoretical foundations for HR
HR also argues that it is an evidence-based
alternative to abstinence. Almost all proponents note studies that
show HR has been quantitatively validated and has, in fact, better
success rates than abstinence programs.
Transtheoretical model of stages of change
Two foundational theories support HR: Prochaska
and DiClemente’s Transtheoretical Model of Stages of Change
(Prochaska, Norcross, & DiClemente, 1995) and Motivation Theory
(Ryan & Deci, 2000). In 1984 a group of addictions researchers
and clinicians arrived in Scotland attempting to find some model
that would offer some way to describe how addicts change addictive
behavior. Two of the participants, James Prochaska and Carlos DiClemente,
had worked out a model of how smokers quit, and subsequent refinements
produced the now famous stages of change model that could be applied
to any treatment program. The model was thus not driven by any theoretical
underpinning; it was developed by observing how addicts found recovery
whether in counseling, 12-step programs, self-management, Minnesota
Model, or other strategy.
The abstinence approach had raised drug use
as the defining difference between recovery and addiction. A single
beer, prescribed mood-altering drug, or use of illegal drugs meant
relapse. The stages of change model dispelled this myth; in fact,
it highlighted two dynamics of recovery that were an affront to
abstinence. First, it pointed out recovery was not an either-or
event; addicts went through a predictable series of definable stages.
Secondly, and most controversial, relapse was a natural stage of
the recovery process. Prochaska and DiClemente observed that only
a tiny percentage of smokers were able to quit on the first attempt.
Despite relapsing, the smokers were serious about quitting and kept
trying until they succeeded. Most of us have known people who diet,
and we recognize that the vast majority of dieters relapse. Few
would condemn them for this because relapsing is the norm for dieters;
the key is to try again. The same dynamic is true for recovery.
Whereas abstinence outcomes counted relapse as a failure, HR maintained
that it was natural and even expected.
Motivation theory
Motivation theory recognized that intrinsic
motivation is the key to successful recovery. Since the first salvo
in the war with the behaviorists was launched in 1971, there has
been disagreement between these schools. Motivational theory seems
to have won out with the publication of Miller and Rollnick’s
(1991) Motivational Interviewing, the highly acclaimed application
of motivation research results to addiction treatment. The key finding
from motivation research showed that modifying behavior through
external punishment and reward obviated internal motivation (Ryan
& Deci, 2000).
Recall James Frey’s (2003) A Million Little
Pieces, in which Frey describes life at Hazelden Treatment Center,
the birthplace of the abstinence-based Minnesota Model. Frey’s
descriptions focus on how clients must act to avoid being discharged—hardly
an inspirational lesson on being motivated for a better life.
Treatment outcomes
Studies that measure abstinence as the sole
criterion of treatment have long since been relegated to library
basements where they are collecting dust. In part, there is a political
reason for this. Under managed care, treatment facilities must justify
their success rates. Because the relapse rate is so high, it is
very difficult to convince insurance companies and other funders
that their money is being spent productively. Beyond this, however,
there is a logic to defining outcomes other than complete freedom
from drugs and alcohol. Because HR clinicians do not see drug use
as the defining feature of addiction, it accepts clients on methadone
and other mood-altering medications, does not discharge clients
in treatment for using, and accepts a client where the client is
at, rather than set standards of behavior and motivation.
The level of drug use is included in outcome
studies but only as one outcome measure. Other measures generally
include physical health, familial relationships, emotional health,
readiness for work or school, and involvement in the criminal justice
system. HR studies have also shown that it saves tax dollars. A
famous (or infamous) report by the Rand Corporation (Rydell &
Everingham, 1994) reported that treatment is 7 times more cost effective
than domestic law enforcement method, 10 times more effective than
interdiction, and 23 times more effective than the ‘source
control’ method. Similarly, the State of California Department
of Drug and Alcohol Programs reported that for every dollar invested
in addictions treatment, 7 dollars was saved in societal costs (Gerstein,
Johnson, Harwood, Fountain, Suter, & Malloy, 1994).
One of the most outstanding successes was reported
by Project MATCH (1997), an eight-year, $27 million study of twelve-step
facilitation (TSF), motivational, and relapse prevention treatment
outcomes. It should be noted that participants were not discharged
for drinking, despite TSF’s abstinence focus. MATCH reported
that 30 percent of participants drank during the first year but
without bingeing. A further 20 percent remained sober. But this
success may not be transportable to other programs. Although Project
MATCH was carefully designed, it has been chastised for, among other
things, its vigorous selection methods in which only stable participants
were selected. A more representative study may be the Baltimore
Drug and Alcohol Treatment Outcomes Study (Johnson, Ahmed, Plemons,
Powell, Carrington, Graham, Hill, Schwartz, & Brooner, 2002).
This study discovered that participants reduced drug behavior at
statistically significant levels over the course of a year. One
year after treatment the Baltimore participants in non-methadone
treatment, for instance, reduced the number of days they binged
from 3.4 days per month from a pre-treatment level of 5.0, although
those participating in the methadone program had slightly increased
number of using days. Significant reductions were also found in
criminal behavior, HIV-risk behavior, and depression. In short,
the participants did not abstain from drugs or risky behavior; they
simply reduced their unhealthy lifestyle sufficiently to attain
statistical significance.
Proponents of harm reduction argue that these
results constitute a major step to success not only for clients
but also for society. In Canada, for instance, the annual per capita
cost to deal with the consequences of addiction (excluding nicotine)
was $725 in 2002 (Rehm, Baliunas, Brochu, Fischer, Gnam, Patra,
Popova, Sarnocinska-Hart, & Taylor, 2006). If one year after
treatment, clients use drugs fewer days per month, have fewer health
problems per month, engage in fewer criminal activities per month,
and so on, this translates into major tax savings and social stability.
Harm reduction and political policy
Inevitably, HR has confronted the traditional
American policy of zero-tolerance. Many tax-funded treatment providers
provide evidence-based harm reduction programs, while public policy
promotes zero-tolerance and the criminalization of drug use. It
is an odd combination that rests uneasily.
Canada, a more liberal environment for drug
issues than America, also feels a tension between abstinence and
harm reduction. The national and provincial governments have unanimously
endorsed harm reduction practices. Vancouver, for instance, has
safe injection and smoking sites, provides heroin to heroin addicts
(with Montreal, as a test city for the North American Opiate Medication
Initiative), needle exchanges, and so on. But the governments of
BC and Canada also make possession of illicit substances a criminal
offence. Vancouver and the surrounding areas are famous for their
homegrown marijuana, known as ‘BC bud’. In fact, marijuana
is so prevalent that law enforcement officers often do not bother
pressing charges for the simple act of smoking a marijuana cigarette.
A friend of mine from Singapore and I were touring Vancouver. She
wanted to see one of our famous ‘hemp’ shops, where
we discovered the cashier happily smoking a joint.
In an open letter to the Secretary General of
the United Nations, eminent citizens declared, “We believe
that the global war on drugs is now causing more harm than drug
abuse itself” (Public letter to Kofi Annan, June 1, 1998).
The signatories were a who’s who of Nobel Prize winners, heads
of state, government ministers, police chiefs, and others. American
signatories included conservatives William, F. Buckley, Jr., Milton
Friedman, and George Shultz. What raised their concern was the growing
awareness that the war on drugs no longer had a moral basis. In
the United States, for instance, 58.9 percent of 1998 inmate population
had been sentenced for drug violations.
The policy of supply and demand reduction also
meant that enforcement was eating up most of the drug budgets. Of
the federal money targeted to ease addiction, 58 percent went to
treatment and prevention in 1970, but by 2000 this had been reduced
to 34 percent (Smith, Runnette, Zill, Bergman, Levis, & Hamilton,
2000).
Key points of HR approach
Principles in the harm reduction literature,
as interpreted in America, report that it is:
- Practical—HR recognizes that drug use
is everywhere. Regardless of our efforts to curb addiction, it
remains the number one health problem in Canada and the United
States.
- Client-centered—Unlike the traditional
psychoanalytical and behavioral theories, HR is rooted in a humanistic
approach. Helpers meet the client where the client is at, rather
than set some arbitrary standard of motivation or behavior.
- Non-coercive—HR is a humane approach
to treatment, and obviates punitive practices such as discharging
a client for using.
- Non-judgmental—HR does not see the
addict as a defective personality and relies on the Rogerian unconditional
positive regard.
- Based on the idea that recovery is a process—HR
does not hold up drug use as the defining feature of addiction
or of treatment failure.
- Success is measured by reduced harm—Rather
than measure success as abstinence, HR sees any reduction in harm
as a successful outcome.
Works cited
Alberta Alcohol and Drug Abuse Commission (AADAC).
(1999). Position on harm reduction. Developments
18(6). Retrieved February 2, 2007 from http://corp.aadac.com/developments/dev_news_vol18_issue6.asp#Position%20on%20Harm%20Reduction
Bruner, J. (1991). The narrative construction of reality. Critical
Inquiry 18(1), 1-22.
Editorial. (2001). Do mainsteam treatment, harm reduction mix? SF
says yes. Alcoholism & Drug Abuse
Weekly 13(5), p. 2.
Frey, J. (2003). A million little
pieces. New York: Random House.
Gerstein, D., Johnson, R.A., Harwood, H., Fountain, D., Suter, N.,
& Malloy, K. (1994). Evaluating recovery services: The California
drug and alcohol treatment assessment. Sacramento, CA: Department
of Alcohol and Drug Programs
Johnson, J.L., Ahmed, A., Plemons, B., Powell, W., Carrington, H.,
Graham, J., Hill, R., Schwartz, R.P., & Brooner, R.K. (2002).
Steps to success: Baltimore drug
and alcohol treatment outcomes study. Baltimore, MD: Baltimore
Substance Abuse Systems, Inc.
Marlatt, A.G. (1998). Harm reduction:
Pragmatic strategies for managing high-risk behaviors. New
York: The Guilford Press.
Miller, W. R., & Rollnick, S. (1991). Motivational
interviewing: Preparing people to change addictive behavior.
New York: Guilford.
Peele, S. (2004). 7 tools to beat
addiction. New York: Three Rivers Press.
Prochaska, J.O., Norcross, J., & DiClemente, C. (1995).
Changing for good. New York: Avon.
Project MATCH. (1997). Matching alcoholism treatments to client
heterogeneity: Project MATCH posttreatment drinking outcomes. National
Institute on Alcohol Abuse and Alcoholism. NIH Pub No. 01-4238.
Public letter to Kofi Annan.
(June 1, 1998). See http://www.csdp.org/edcs/figure25.htm.
Rehm, J., Ballunas, D., Brochu, S., Fischer, B., Gnam, W., Patra,
J., Popova, S., Sarnocinska-Hart, A., & Taylor, B. (2006). The
costs of substance abuse in Canada 2002. Ottawa, ON: Canadian
Centre on Substance Abuse.
Ryan, R.M., & Deci, E.L. (2000). Self-determination
theory and the facilitation of intrinsic motivation, social development,
and well-being. American Psychologist,
55, 68-78.
Rydell, C.P., & Everingham, S.S. (1994). Controlling
cocaine: Supply versus demand programs.
Santa Monica, CA: Rand.
Smith, M., Runnette, B., Zill, O., Bergman, L., Levis, K., &
Hamilton, D. (October 9-10, 2000). Drug Wars.
Frontline. See http://www.pbs.org/wgbh/frontline/shows/drugs/buyers/doitwork.html
|